These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 12269373
1. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 1998 Sep 21; 63(182):50244-9. PubMed ID: 12269373 [Abstract] [Full Text] [Related]
2. International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS. Fed Regist; 1999 Aug 18; 64(159):44928-35. PubMed ID: 12356094 [Abstract] [Full Text] [Related]
3. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2005 Jun 30; 70(125):37861-2. PubMed ID: 15988855 [Abstract] [Full Text] [Related]
5. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 Oct 16; 66(200):52634-7. PubMed ID: 12358037 [Abstract] [Full Text] [Related]
10. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS. Fed Regist; 1998 Feb 23; 63(35):8983-6. PubMed ID: 12269370 [Abstract] [Full Text] [Related]
12. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2000 Dec 15; 65(242):78493-4. PubMed ID: 12362934 [Abstract] [Full Text] [Related]
14. International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice. Food and Drug Administration, HHS. Fed Regist; 2000 Dec 29; 65(251):83041-63. PubMed ID: 12356095 [Abstract] [Full Text] [Related]
15. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Nov 14; 68(220):64628-9. PubMed ID: 14619944 [Abstract] [Full Text] [Related]
19. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Feb 11; 68(28):6924-5. PubMed ID: 12583358 [Abstract] [Full Text] [Related]
20. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Apr 08; 74(66):15990-1. PubMed ID: 19507321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]